London · Delayed Price · Currency is GBP · Price in GBX Dr. Martens Statistics
Total Valuation
Dr. Martens has a market cap or net worth of GBP 658.65 million. The enterprise value is 960.05 million.
| Market Cap | 658.65M |
| Enterprise Value | 960.05M |
Important Dates
The last earnings date was Friday, January 23, 2026.
| Earnings Date | Jan 23, 2026 |
| Ex-Dividend Date | Mar 5, 2026 |
Share Statistics
Dr. Martens has 967.30 million shares outstanding. The number of shares has increased by 4.49% in one year.
| Current Share Class | 967.30M |
| Shares Outstanding | 967.30M |
| Shares Change (YoY) | +4.49% |
| Shares Change (QoQ) | -0.27% |
| Owned by Insiders (%) | 1.01% |
| Owned by Institutions (%) | 51.63% |
| Float | 520.13M |
Valuation Ratios
The trailing PE ratio is 44.04 and the forward PE ratio is 14.55. Dr. Martens's PEG ratio is 0.47.
| PE Ratio | 44.04 |
| Forward PE | 14.55 |
| PS Ratio | 0.84 |
| PB Ratio | 2.00 |
| P/TBV Ratio | 11.74 |
| P/FCF Ratio | 4.53 |
| P/OCF Ratio | 4.28 |
| PEG Ratio | 0.47 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.33, with an EV/FCF ratio of 6.60.
| EV / Earnings | 62.75 |
| EV / Sales | 1.22 |
| EV / EBITDA | 7.33 |
| EV / EBIT | 14.37 |
| EV / FCF | 6.60 |
Financial Position
The company has a current ratio of 2.18, with a Debt / Equity ratio of 1.21.
| Current Ratio | 2.18 |
| Quick Ratio | 1.08 |
| Debt / Equity | 1.21 |
| Debt / EBITDA | 3.03 |
| Debt / FCF | 2.73 |
| Interest Coverage | 2.30 |
Financial Efficiency
Return on equity (ROE) is 4.61% and return on invested capital (ROIC) is 6.12%.
| Return on Equity (ROE) | 4.61% |
| Return on Assets (ROA) | 4.64% |
| Return on Invested Capital (ROIC) | 6.12% |
| Return on Capital Employed (ROCE) | 9.77% |
| Weighted Average Cost of Capital (WACC) | 5.06% |
| Revenue Per Employee | 212,162 |
| Profits Per Employee | 4,135 |
| Employee Count | 3,700 |
| Asset Turnover | 0.87 |
| Inventory Turnover | 1.22 |
Taxes
In the past 12 months, Dr. Martens has paid 11.20 million in taxes.
| Income Tax | 11.20M |
| Effective Tax Rate | 42.26% |
Stock Price Statistics
The stock price has decreased by -4.37% in the last 52 weeks. The beta is 0.24, so Dr. Martens's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | -4.37% |
| 50-Day Moving Average | 76.01 |
| 200-Day Moving Average | 77.83 |
| Relative Strength Index (RSI) | 29.70 |
| Average Volume (20 Days) | 1,621,974 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr. Martens had revenue of GBP 785.00 million and earned 15.30 million in profits. Earnings per share was 0.02.
| Revenue | 785.00M |
| Gross Profit | 514.30M |
| Operating Income | 66.80M |
| Pretax Income | 26.50M |
| Net Income | 15.30M |
| EBITDA | 80.90M |
| EBIT | 66.80M |
| Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 95.70 million in cash and 397.10 million in debt, with a net cash position of -301.40 million or -0.31 per share.
| Cash & Cash Equivalents | 95.70M |
| Total Debt | 397.10M |
| Net Cash | -301.40M |
| Net Cash Per Share | -0.31 |
| Equity (Book Value) | 329.10M |
| Book Value Per Share | 0.34 |
| Working Capital | 214.80M |
Cash Flow
In the last 12 months, operating cash flow was 153.80 million and capital expenditures -8.40 million, giving a free cash flow of 145.40 million.
| Operating Cash Flow | 153.80M |
| Capital Expenditures | -8.40M |
| Free Cash Flow | 145.40M |
| FCF Per Share | 0.15 |
Margins
Gross margin is 65.52%, with operating and profit margins of 8.51% and 1.95%.
| Gross Margin | 65.52% |
| Operating Margin | 8.51% |
| Pretax Margin | 3.38% |
| Profit Margin | 1.95% |
| EBITDA Margin | 10.31% |
| EBIT Margin | 8.51% |
| FCF Margin | 18.52% |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 3.88%.
| Dividend Per Share | 0.03 |
| Dividend Yield | 3.88% |
| Dividend Growth (YoY) | 38.59% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 115.69% |
| Buyback Yield | -4.49% |
| Shareholder Yield | -0.68% |
| Earnings Yield | 2.32% |
| FCF Yield | 22.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Dr. Martens has an Altman Z-Score of 4.97 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.97 |
| Piotroski F-Score | 6 |